The Global Biosimilars Market was valued at USD 29.51 billion in 2023 and is projected to reach USD 127.92 billion by 2032, growing at a compound annual growth rate (CAGR) of 17.7% over the forecast period from 2024 to 2032. The market's expansion is driven by increasing adoption of biosimilars due to their cost-effectiveness, rising prevalence of chronic...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian